Navellier & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,572	Closed	-$516K	–	361
2025 Q3	$516K	Buy	+3,572	New	+$488K	0.05%	256
2024 Q3	–	Sell	-3,565	Closed	-$489K	–	336
2024 Q2	$489K	Buy	+3,565	New	+$476K	0.06%	244
2021 Q4	–	Sell	-2,316	Closed	-$374K	–	334
2021 Q3	$374K	Buy	+2,316	New	+$390K	0.06%	233
2021 Q2	–	Sell	-3,303	Closed	-$497K	–	323
2021 Q1	$497K	Buy	+3,303	New	+$525K	0.09%	179
2020 Q1	–	Sell	-17,677	Closed	-$2.13M	–	262
2019 Q4	$2.13M	Buy	+17,677	New	+$1.97M	0.34%	84
2018 Q4	–	Sell	-62,187	Closed	-$7.58M	–	265
2018 Q3	$7.58M	Buy	+62,187	New	+$7.32M	0.98%	26
2018 Q1	–	Sell	-6,750	Closed	-$721K	–	318
2017 Q4	$721K	Buy	+6,750	New	+$722K	0.13%	157
2017 Q1	–	Sell	-40,095	Closed	-$3.55M	–	297
2016 Q4	$3.55M	Buy	40,095 +6,366	+19%	+$579K	0.59%	73
2016 Q3	$3.25M	Buy	+33,729	New	+$3.21M	0.47%	72
2015 Q3	–	Sell	-12,465	Closed	-$1.53M	–	345
2015 Q2	$1.53M	Buy	12,465 +3,051	+32%	+$365K	0.13%	85
2015 Q1	$1.08M	Buy	+9,414	New	+$1.04M	0.1%	105